Your browser doesn't support javascript.
loading
Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
Gaschet, J; Lim, A; Liem, L; Vivien, R; Hallet, M M; Harousseau, J L; Even, J; Goulmy, E; Bonneville, M; Milpied, N; Vié, H.
Afiliación
  • Gaschet J; Insitut National de la Santé et de Recherche Médicale, Plateau Technique du CHR, Mantes, France.
J Clin Invest ; 98(1): 100-7, 1996 Jul 01.
Article en En | MEDLINE | ID: mdl-8690780
ABSTRACT
Analysis of a large number of unrelated bone marrow transplantations (BMT) has shown that HLA-DP incompatibility did not detectably influence the risk for acute graft-versus-host disease (aGVHD). Accordingly, it was proposed that HLA-DP determinants did not function as transplantation antigens in the same way as HLA-A, -B, or -DR. We have previously shown that HLA-DP (as well as HLA-A, -B, -DQ, or -DR)-specific T cells could be isolated from skin biopsies of patients who developed an aGVHD after semiallogeneic BMT. Nevertheless, whether a single HLA-DP mismatched allele could induce a detectable allo-specific reaction in vivo after BMT remained to be established. To directly address this issue we studied one patient who presented aGVHD after receiving purified CD34+ bone marrow (BM) cells from an unrelated donor with a single HLA-DP mismatch in the GVHD direction. To characterize the immunological events associated with GVHD, we analyzed the peripheral T cell repertoire, the T cell receptor Vbeta diversity, and the specificity of T cells invading a skin biopsy at the onset of GVHD. Our results demonstrated that a large fraction of skin-infiltrating lymphocytes, which expressed diverse T cell receptors, were reactive against this single HLA-DPB1 *0501 mismatch and consequently that a single HLA-DP mismatch between BM donor and recipient can activate a strong T cell response in vivo.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Leucemia Mielógena Crónica BCR-ABL Positiva / Antígenos HLA-DP / Trasplante de Médula Ósea / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Invest Año: 1996 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Leucemia Mielógena Crónica BCR-ABL Positiva / Antígenos HLA-DP / Trasplante de Médula Ósea / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Invest Año: 1996 Tipo del documento: Article País de afiliación: Francia